INS and epilepsy: This factor can bind to insulin and IGF-I receptors, mimicking endogenous insulin effects, increasing glucose uptake by tissues, and inhibiting growth hormone secretion and its hypoglycemia regulatory response, resulting in hypoglycemia and, in severe cases, epilepsy (89).